117 related articles for article (PubMed ID: 1461657)
1. Alternative splicing in the human lck gene leads to the deletion of exon 1' and results in a new type II lck transcript.
Rouer E; Benarous R
Oncogene; 1992 Dec; 7(12):2535-8. PubMed ID: 1461657
[TBL] [Abstract][Full Text] [Related]
2. Pattern of expression of five alternative transcripts of the lck gene in different hematopoietic malignancies: correlation of the level of lck messenger RNA I B with the immature phenotype of the malignancy.
Rouer E; Dreyfus F; Melle J; Benarous R
Cell Growth Differ; 1994 Jun; 5(6):659-66. PubMed ID: 8086341
[TBL] [Abstract][Full Text] [Related]
3. Frequent activation of the lck gene by promoter insertion and aberrant splicing in murine leukemia virus-induced rat lymphomas.
Shin S; Steffen DL
Oncogene; 1993 Jan; 8(1):141-9. PubMed ID: 8423992
[TBL] [Abstract][Full Text] [Related]
4. Expression of alternatively spliced lck transcripts from the proximal promoter in colorectal cancer derived cell lines.
Mayer K; Ballhausen WG
Anticancer Res; 1996; 16(4A):1733-7. PubMed ID: 8712692
[TBL] [Abstract][Full Text] [Related]
5. A rare mRNA variant of the human lymphocyte-specific protein tyrosine kinase LCK gene with intron B retention and exon 7 skipping encodes a putative protein with altered SH3-dependent molecular interactions.
Nervi S; Guinamard R; Delaval B; Lécine P; Vialettes B; Naquet P; Imbert J
Gene; 2005 Oct; 359():18-25. PubMed ID: 16107303
[TBL] [Abstract][Full Text] [Related]
6. A single base mutation in the 5' splice site of intron 7 of the lck gene is responsible for the deletion of exon 7 in lck mRNA of the JCaM1 cell line.
Rouer E; Brule F; Benarous R
Oncogene; 1999 Jul; 18(29):4262-8. PubMed ID: 10435639
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of two classes of lck transcripts upon phorbol ester treatment of human leukemic T cells.
Leung S; Miyamoto NG
J Cell Physiol; 1991 Sep; 148(3):344-52. PubMed ID: 1918168
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of transforming variants of the lck tyrosine protein kinase.
Adler HT; Sefton BM
Oncogene; 1992 Jun; 7(6):1191-9. PubMed ID: 1594248
[TBL] [Abstract][Full Text] [Related]
9. Requirement of an ETS-binding element for transcription of the human lck type I promoter.
Leung S; McCracken S; Ghysdael J; Miyamoto NG
Oncogene; 1993 Apr; 8(4):989-97. PubMed ID: 8455950
[TBL] [Abstract][Full Text] [Related]
10. Structure function analysis of SH2D2A isoforms expressed in T cells reveals a crucial role for the proline rich region encoded by SH2D2A exon 7.
Granum S; Sundvold-Gjerstad V; Dai KZ; Kolltveit KM; Hildebrand K; Huitfeldt HS; Lea T; Spurkland A
BMC Immunol; 2006 Jul; 7():15. PubMed ID: 16839418
[TBL] [Abstract][Full Text] [Related]
11. Identification of an alternatively spliced transcript of human interleukin-4 lacking the sequence encoded by exon 2.
Sorg RV; Enczmann J; Sorg UR; Schneider EM; Wernet P
Exp Hematol; 1993 Apr; 21(4):560-3. PubMed ID: 8462665
[TBL] [Abstract][Full Text] [Related]
12. Genomic organization and structure of the 5'-flanking region of the TEX101 gene: alternative promoter usage and splicing generate transcript variants with distinct 5'-untranslated region.
Tsukamoto H; Takizawa T; Takamori K; Ogawa H; Araki Y
Mol Reprod Dev; 2007 Feb; 74(2):154-62. PubMed ID: 16941676
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter.
Nishio H; Takeshima Y; Narita N; Yanagawa H; Suzuki Y; Ishikawa Y; Ishikawa Y; Minami R; Nakamura H; Matsuo M
J Clin Invest; 1994 Sep; 94(3):1037-42. PubMed ID: 8083345
[TBL] [Abstract][Full Text] [Related]
14. An additional exon of stress-inducible heat shock protein 70 gene (HSP70-1).
Shimizu S; Nomura K; Ujihara M; Demura H
Biochem Biophys Res Commun; 1999 Apr; 257(1):193-8. PubMed ID: 10092532
[TBL] [Abstract][Full Text] [Related]
15. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
McCracken S; Leung S; Bosselut R; Ghysdael J; Miyamoto NG
Oncogene; 1994 Dec; 9(12):3609-15. PubMed ID: 7970721
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines.
Meazza R; Verdiani S; Biassoni R; Coppolecchia M; Gaggero A; Orengo AM; Colombo MP; Azzarone B; Ferrini S
Oncogene; 1996 May; 12(10):2187-92. PubMed ID: 8668345
[TBL] [Abstract][Full Text] [Related]
17. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
Lee PL; Gelbart T; West C; Halloran C; Beutler E
Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript.
De Rosa M; Morelli G; Cesaro E; Duraturo F; Turano M; Rossi GB; Delrio P; Izzo P
Gene; 2007 Jun; 395(1-2):8-14. PubMed ID: 17360132
[TBL] [Abstract][Full Text] [Related]
19. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
Zhang DL; Ji L; Li YD
Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
[TBL] [Abstract][Full Text] [Related]
20. Four murine c-abl mRNAs arise by usage of two transcriptional promoters and alternative splicing.
Bernards A; Paskind M; Baltimore D
Oncogene; 1988 Apr; 2(4):297-304. PubMed ID: 3283651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
